Agilent and MGI collaborate to integrate lab software NEWS


LABORATORY INFORMATICS


Agilent Technologies and MGI Tech have signed an agreement to conduct a more in-depth cooperation in high throughput sequencing, to provide a more efficient and reliable high-throughput sequencing technology. DNBSEQ is the basic core technology of MGI’s sequencing instrument, including DNA single-chain circularisation and DNB preparation, patterned array slides, DNB loading, cPAS (combinatorial probe anchor synthesis), paired-end sequencing, and base calling algorithms. The technology has the important


characteristics of high accuracy, low duplicate rate, and low index hopping, which can effectively avoid the accumulation of errors in traditional PCR sequencing. With DNBSEQ as the core, MGI has


developed a series of sequencing platforms covering high, medium and low throughput and various application scenarios. Liu Jian, executive VP of MGI, said:


‘This cooperation has fully utilised the advantages of both parties, and we look forward to further enhancing the efficiency of laboratory operations to provide better service for more customers in the application field through cooperation between the two parties.’ Agilent SLIMS is a laboratory management solution that combines laboratory information management systems (LIMS) and electronic lab record (ELN) functions, including electronic lab notebooks, sample management, workflow management, order management, and data display boards. The five main functional modules can be applied to biological sample bank, medical industry QA/QC, high-throughput sequencing, analytical laboratories, clinical diagnosis and other industries, which is in line with the requirements of laws and regulations in many regions of the world. Through this cooperation, Agilent’s SLIMS laboratory information system will be deeply integrated with MGI’s DNBSEQ series of sequencing platforms and other diversified life science instruments to achieve seamless connection between hardware and software. John Sadler, Agilent VP and GM of


its software and informatics division, commented: ‘The Agilent SLIMS teams look forward to a long-term and fruitful cooperation with MGI.’


www.scientific-computing.com | @scwmagazine


Sectra and Leica Biosystems collaborate on integrated clinical digital pathology International medical imaging IT and cybersecurity company Sectra and Leica Biosystems have announced collaboration for an integrated clinical pathology solution. The goal is to address the clinical needs of enterprise-level customers such as academic medical centres, clinical research organisations and large hospital networks.


A 510(k) application for the combined


solution has been submitted to the US Food & Drug Administration (FDA). ‘Leveraging Leica Biosystems existing 510(k) clearance for its Aperio AT2 DX scanner, and extending it with the Sectra Digital Pathology Solution for hospitals and health systems, enable us to deliver a clinical solution to meet the needs of the truly integrated digital hospitals of today and tomorrow,’ says Torbjörn Kronander, founder and CEO of Sectra. ‘This is an exciting and important advancement for the clinical pathology industry and a huge step forward in clinical usability.’ The Sectra digital pathology software


solution, a component of the enterprise imaging offering, will facilitate streamlined


image access, review, and diagnosis, as well as deep integration with leading pathology information systems and EMRs. Leica Biosystems Aperio AT2 DX system is a high-throughput automated digital scanner that delivers diagnostic-quality whole slide images. The integration of these two solid platforms will enable clinical organisations to deliver a scalable, unified solution for optimised patient care and financial outcomes. Leica Biosystems says it is committed


to investing in the development of Aperio Digital Pathology software, image analysis and hardware solutions. Leica Biosystems says it recognises the need for a wide variety of use cases and applications which simply cannot be addressed by a single provider. Leica Biosystems’ open platform will enable customers to choose their preferred workflow solutions. ‘This is an important step towards


improving patient care with digital technology,’ says Colin White, global VP of Leica Biosystems Advanced Staining and Imaging Business. ‘We look forward to working with Sectra to offer streamlined digital pathology solutions for clinical organisations.’


December 2019/January 2020 Scientific Computing World 25


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28